Literature DB >> 2973745

Growth studies in infants and children with Down's syndrome and elevated levels of thyrotropin.

T Sharav1, R M Collins, P J Baab.   

Abstract

A retrospective survey of 147 patients with Down's syndrome (age range, 4 months to 27 years) showed that 60% had a thyrotropin (TSH) level higher than 5.7 mU/L in the presence of high or normal thyroxine levels. The remaining 40% of the group had low to normal TSH values. High TSH levels were predominant in patients under 4 years of age (94 children), ie, during the phase of active growth, and showed a declining trend with increasing age. All 94 infants had delayed growth of all parameters including head circumference, height, and weight, as compared with normal infants, and growth was particularly retarded in patients with TSH levels greater than 5.7 mU/L. Thyroid dysfunction, expressed as a high TSH concentration, is associated with growth retardation in children with Down's syndrome who are younger than 4 years.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973745     DOI: 10.1001/archpedi.1988.02150120056040

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  15 in total

1.  Hypothyroidism in Down syndrome: screening guidelines and testing methodology.

Authors:  Olga Hardy; Gordon Worley; Mary M Lee; Shu Chaing; Joanne Mackey; Blythe Crissman; Priya Sunil Kishnani
Journal:  Am J Med Genet A       Date:  2004-02-01       Impact factor: 2.802

2.  Thyroid antibodies as a risk factor for Down syndrome and other trisomies.

Authors:  C P Torfs; B J van den Berg; F W Oechsli; R E Christianson
Journal:  Am J Hum Genet       Date:  1990-10       Impact factor: 11.025

3.  Higher serum thyroid autoantibody value is a risk factor of hypothyroidism in children and young adults with chronic thyroiditis.

Authors:  Kazuhiro Shimura; Kanako Yoshizaki; Yukihiro Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2022-05-29

4.  Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity.

Authors:  B Karlsson; J Gustafsson; G Hedov; S A Ivarsson; G Annerén
Journal:  Arch Dis Child       Date:  1998-09       Impact factor: 3.791

Review 5.  Endocrine and musculoskeletal abnormalities in patients with Down syndrome.

Authors:  Yousra Hawli; Mona Nasrallah; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

6.  Thyroid function and plasma immunoglobulins in subjects with Down's syndrome (DS) during ontogenesis and zinc therapy.

Authors:  M Sustrová; V Strbák
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

7.  TSH receptor and Gs(alpha) genetic analysis in children with Down's syndrome and subclinical hypothyroidism.

Authors:  M Tonacchera; A Perri; G De Marco; P Agretti; L Montanelli; M E Banco; A Corrias; J Bellone; M T Tosi; P Vitti; E Martino; A Pinchera; L Chiovato
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

Review 8.  Thyroid dysfunction in children with Down syndrome: a literature review.

Authors:  K King; C O'Gorman; S Gallagher
Journal:  Ir J Med Sci       Date:  2013-08-10       Impact factor: 1.568

9.  New cross sectional stature, weight, and head circumference references for Down's syndrome in the UK and Republic of Ireland.

Authors:  M E Styles; T J Cole; J Dennis; M A Preece
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

10.  Profile of hypothyroidism in Down's syndrome.

Authors:  Ayşe Nurcan Cebeci; Ayla Güven; Metin Yıldız
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.